IP Library Assignment 065607/0673
Patent Assignment
Reel/Frame 065607/0673

Assignment of Assignor's Interest

Recorded: 2023-11-17 Pages: 3
Assignor
EIDOS THERAPEUTICS, INC.
Executed: 2023-01-26
Assignee
CALCILYTIX THERAPEUTICS, INC.
1800 OWENS ST., STE. C-1200, SAN FRANCISCO, CALIFORNIA, 94158
Covered Property (1)
Formulations of Triphenyl Calcilytic Compounds
Application: 18/216,536 →
Publication: US 2024/0074978
Related Assignments (5)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest Nov 17, 2023
From: PRASAD, LEENA; KOMEYLI, ALI
To: CALCILYTIX THERAPEUTICS, INC.
Reel/Frame 065607/0640 →
Assignment of Assignor's Interest Nov 17, 2023
From: SINHA, UMA; SRIDHAR, ANANTH
To: EIDOS THERAPEUTICS, INC.
Reel/Frame 065607/0645 →
Security Interest Jan 17, 2024
From: CALCILYTIX THERAPEUTICS INC.; ADRENAS THERAPEUTICS INC.; PHOENIX TISSUE REPAIR, INC.; NAVIRE PHARMA, INC.
To: BLUE OWL CAPITAL CORPORATION, AS ADMINISTRATIVE AGENT
Reel/Frame 066342/0154 →
Security Interest Jan 19, 2024
From: BRIDGEBIO PHARMA, INC.; QED THERAPEUTICS, INC.; EIDOS THERAPEUTICS, INC.; THERAS, INC.
To: BLUE OWL CAPITAL CORPORATION, AS ADMINISTRATIVE AGENT
Reel/Frame 066355/0126 →
Release of Security Interest in Patent Collateral Mar 5, 2025
From: BLUE OWL CAPITAL CORPORATION, AS ADMINISTRATIVE AGENT
To: BRIDGEBIO PHARMA, INC.; QED THERAPEUTICS, INC.; EIDOS THERAPEUTICS, INC.; ML BIO SOLUTIONS INC.
Reel/Frame 070551/0095 →